A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.

Clinical trial NCT07652658 · RECRUITING

Trial details

NCT number: NCT07652658
Sponsor: AstraZeneca
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Idiopathic Pulmonary Fibrosis (IPF)

Start date: 2026-06-11
Primary completion: 2028-09-14
Enrollment: 359

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.